National Advisory Committee on Immunization (NACI). (2024) NACI Rapid Response: Interim guidance on the use of Imvamune in the context of monkeypox outbreaks in Canada Ottawa (ON): Government of Canada: Government of Canada; 2022 Nov 09 https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/guidance-imvamune-monkeypox.html.
Akter, F., Hasan, T. B., Alam, F., Das, A., Afrin, S., Maisha, S., ... & KM, S. U. R. (2023). Effect of prior immunisation with smallpox vaccine for protection against human Mpox: a systematic review. Reviews in Medical Virology, 33(4), e2444. https://doi.org/10.1002/rmv.2444
Malone, S. M., Mitra, A. K., Onumah, N. A., Brown, A., Jones, L. M., Tresvant, D. C., ... & Iseguede, F. O. (2023). Safety and efficacy of post-eradication smallpox vaccine as an mpox vaccine: a systematic review with meta-analysis. International Journal of Environmental Research and Public Health, 20(4), 2963.https://doi.org/10.3390/ijerph20042963
STIKO. 2023. Recommendations by the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute – 2023. https://www.rki.de/EN/Content/infections/Vaccination/recommandations/04_23_englisch.pdf?__blob=publicationFile
SAGE. 2022. Vaccines and immunization for monkeypox: Interim guidance, 16 November 2022. https://www.who.int/publications/i/item/WHO-MPX-Immunization
